BRIEF published on 06/16/2026 at 08:05, 4 months 25 days ago Aquis Stock Exchange: Reveille Resources Pursues Admission to Growth Market Uranium Exploration Aquis Growth Market Nuclear Energy European Projects Reveille Resources
BRIEF published on 06/16/2026 at 08:05, 4 months 25 days ago Bourse d'Aquis : Reveille Resources vise l'admission au marché de croissance Énergie Nucléaire Exploration De L'uranium Marché De Croissance Aquis Projets Européens Ressources De Reveille
BRIEF published on 06/16/2026 at 08:05, 4 months 25 days ago Vusion Strengthens Partnership with JYSK Across Europe European Expansion Cloud Transition Vusion JYSK Retail Modernization
BRIEF published on 06/16/2026 at 08:05, 4 months 25 days ago Vusion renforce son partenariat cloud avec JYSK Cloud Computing Étiquettes Électroniques Commerce Digital Vusion JYSK
BRIEF published on 06/16/2026 at 08:05, 4 months 25 days ago Vusion renforce son partenariat avec JYSK à travers l'Europe Expansion Européenne Transition Vers Le Cloud Vusion JYSK Modernisation Du Commerce De Détail
BRIEF published on 06/16/2026 at 08:05, 4 months 25 days ago THX Pharma : Allinvest Securities Recommande l'Achat du Titre Partenariats Stratégiques Maladies Rares AllInvest Securities Bio-pharmaceutique THX Pharma
BRIEF published on 06/16/2026 at 08:05, 4 months 25 days ago Vusion strengthens its cloud partnership with JYSK Cloud Computing Digital Commerce Electronic Labels Vision JYSK
BRIEF published on 06/16/2026 at 08:05, 4 months 25 days ago Allinvest Securities Backs THX Pharma with Optimistic Buy Recommendation Buy Recommendation Partnerships Rare Diseases AllInvest Securities THX Pharma
BRIEF published on 06/16/2026 at 08:05, 4 months 25 days ago THX Pharma: Allinvest Securities Recommends Buying the Stock Strategic Partnerships Biopharmaceutical Rare Diseases AllInvest Securities THX Pharma
BRIEF published on 06/16/2026 at 08:05, 4 months 25 days ago Allinvest Securities soutient THX Pharma avec une recommandation d'achat optimiste Partenariats Recommandation D'achat Maladies Rares AllInvest Securities THX Pharma
Published on 11/11/2026 at 10:30, 1 hour 19 minutes ago Temas Engages Arcstone Canada for Capital Markets Advisory and Investor-Communications Services
Published on 11/11/2026 at 03:30, 8 hours 19 minutes ago CoTec Holdings Corp. Files Third Quarter Financial Statements and MD&A and Provides Market Commentary
Published on 11/11/2026 at 00:40, 11 hours 9 minutes ago Upgraded Tunkillia MRE Validates Optimised Scoping Study
Published on 11/10/2026 at 23:30, 12 hours 19 minutes ago CCL Industries Announces 2026 Third Quarter Results
Published on 11/10/2026 at 23:00, 12 hours 49 minutes ago Vanta Announces Appointment of Chief Financial Officer and Corporate Secretary
Published on 11/11/2026 at 11:18, 30 minutes ago Original-Research: Cantourage Group SE (von First Berlin Equity Research GmbH): Kaufen
Published on 11/11/2026 at 11:11, 37 minutes ago EQS-Adhoc: ABO Energy GmbH & Co. KGaA intends to notify a Restructuring Project under the StaRUG
Published on 11/11/2026 at 10:10, 1 hour 39 minutes ago EQS-Adhoc: Hapag-Lloyd further raises its earnings outlook for the current financial year
Published on 11/11/2026 at 10:00, 1 hour 49 minutes ago GBC AG and Apaton Finance invite investors to the Zefiro Investor Day on November 19, 2026
Published on 11/11/2026 at 09:40, 2 hours 8 minutes ago Disclosure according to Article 5(1)(b) of the EU Regulation No. 596/2014 and Article 2(3) of the Delegated EU Regulation No. 2016/1052 - 1st Interim Report
Published on 11/10/2026 at 18:00, 17 hours 49 minutes ago Déclaration du nombre total des droits de vote et du nombre d’actions au 31 octobre 2026
Published on 11/10/2026 at 17:45, 18 hours 4 minutes ago Damartex / Descriptif du programme de rachat d'actions
Published on 11/10/2026 at 17:35, 18 hours 14 minutes ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 octobre 2026
Published on 11/10/2026 at 17:31, 18 hours 17 minutes ago CNP Assurances SA annonce le succès de l’émission d’une obligation subordonnée Tier 2 de 500 M€.
